Johnson & Johnson starts phase three trial testing of COVID-19 vaccine candidate
- 4 years ago
존슨앤드존슨, 코로나 백신 3상 임상시험 착수…미국서 4번째
American drugmaker Johnson and Johnson has begun its phase three trial of its COVID-19 vaccine candidate.
Johnson and Johnson is now the fourth drugmaker backed by the Trump administration to enter late-stage testing after Moderna, Pfizer and AstraZeneca.
Johnson and Johnson's trial will enroll up to 60-thousand adult volunteers across 215 locations in the U.S. and other countries.
The company expects possible vaccine batches for potential emergency use authorization to be available early next year.
American drugmaker Johnson and Johnson has begun its phase three trial of its COVID-19 vaccine candidate.
Johnson and Johnson is now the fourth drugmaker backed by the Trump administration to enter late-stage testing after Moderna, Pfizer and AstraZeneca.
Johnson and Johnson's trial will enroll up to 60-thousand adult volunteers across 215 locations in the U.S. and other countries.
The company expects possible vaccine batches for potential emergency use authorization to be available early next year.